Prasad S. Adusumilli

21.0k total citations · 5 hit papers
310 papers, 12.1k citations indexed

About

Prasad S. Adusumilli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Prasad S. Adusumilli has authored 310 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Pulmonary and Respiratory Medicine, 109 papers in Oncology and 55 papers in Surgery. Recurrent topics in Prasad S. Adusumilli's work include Lung Cancer Diagnosis and Treatment (99 papers), Lung Cancer Treatments and Mutations (65 papers) and CAR-T cell therapy research (49 papers). Prasad S. Adusumilli is often cited by papers focused on Lung Cancer Diagnosis and Treatment (99 papers), Lung Cancer Treatments and Mutations (65 papers) and CAR-T cell therapy research (49 papers). Prasad S. Adusumilli collaborates with scholars based in United States, Japan and China. Prasad S. Adusumilli's co-authors include David R. Jones, Valerie W. Rusch, William D. Travis, Camelia S. Sima, Kyuichi Kadota, Michel Sadelain, Jonathan Villena‐Vargas, Leonid Cherkassky, Aurore Morello and Nabil P. Rizk and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Prasad S. Adusumilli

294 papers receiving 12.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

2016 803 citations Aurore Morello, Jonathan Villena‐Vargas et al. profile →
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

2014 434 citations Prasad S. Adusumilli, Jonathan Villena‐Vargas et al. profile →
Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas

2015 416 citations Kyuichi Kadota, Jun‐ichi Nitadori et al. Journal of Thoracic Oncology profile →
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors

2019 405 citations Prasad S. Adusumilli et al. profile →
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

2015 367 citations Aurore Morello, Michel Sadelain et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Prasad S. Adusumilli United States	59	6.4k	5.4k	1.9k	1.8k	1.8k	310	12.1k
Kenneth K. Tanabe United States	58	2.0k 0.3×	4.4k 0.8×	1.9k 1.1×	3.2k 1.8×	800 0.5×	236	11.6k
David Raben United States	48	5.6k 0.9×	6.8k 1.3×	3.7k 2.0×	4.4k 2.5×	1.1k 0.6×	236	15.2k
Aurélien Marabelle France	63	3.1k 0.5×	10.2k 1.9×	1.2k 0.6×	2.8k 1.5×	5.8k 3.3×	281	15.2k
José Luis Perez‐Gracia Spain	51	5.0k 0.8×	10.4k 1.9×	1.2k 0.6×	2.8k 1.6×	5.7k 3.2×	191	15.2k
Simone Mocellin Italy	59	2.3k 0.4×	5.2k 1.0×	1.9k 1.0×	3.2k 1.8×	3.1k 1.7×	279	11.8k
Masayuki Noguchi Japan	56	5.4k 0.8×	5.4k 1.0×	1.5k 0.8×	4.2k 2.4×	4.5k 2.6×	352	16.8k
Dirk Jäger Germany	48	1.9k 0.3×	6.8k 1.3×	1.9k 1.0×	2.9k 1.6×	3.4k 1.9×	220	11.8k
James L. Gulley United States	71	5.7k 0.9×	11.7k 2.2×	1.9k 1.0×	4.2k 2.3×	8.3k 4.7×	568	18.4k
Paul M. Harari United States	60	7.2k 1.1×	8.6k 1.6×	4.0k 2.2×	4.7k 2.6×	863 0.5×	303	18.1k
Barbara Burtness United States	56	5.0k 0.8×	8.5k 1.6×	3.7k 2.0×	4.4k 2.5×	2.0k 1.1×	363	16.0k

Countries citing papers authored by Prasad S. Adusumilli

Since Specialization

Citations

This map shows the geographic impact of Prasad S. Adusumilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasad S. Adusumilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasad S. Adusumilli more than expected).

Fields of papers citing papers by Prasad S. Adusumilli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasad S. Adusumilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasad S. Adusumilli. The network helps show where Prasad S. Adusumilli may publish in the future.

Co-authorship network of co-authors of Prasad S. Adusumilli

This figure shows the co-authorship network connecting the top 25 collaborators of Prasad S. Adusumilli. A scholar is included among the top collaborators of Prasad S. Adusumilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasad S. Adusumilli. Prasad S. Adusumilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhat, Hina F., et al.. (2024). Combinational CAR T-cell therapy for solid tumors: Requisites, rationales, and trials. Pharmacology & Therapeutics. 266. 108763–108763. 6 indexed citations

Husta, Bryan, I‐Hsin Lin, Prasad S. Adusumilli, et al.. (2024). The incremental contribution of mobile cone-beam computed tomography to the tool–lesion relationship during shape-sensing robotic-assisted bronchoscopy. ERJ Open Research. 10(4). 993–2023. 7 indexed citations

Fick, Cameron N., Kay See Tan, Brooke Mastrogiacomo, et al.. (2024). Late recurrence of completely resected stage I to IIIA lung adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 169(2). 445–453.e3. 4 indexed citations

Kalchiem‐Dekel, Or, Xiaoyue Ma, Paul J. Christos, et al.. (2024). Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy. Respirology. 29(9). 803–814. 6 indexed citations

Fick, Cameron N., Kay See Tan, Gaetano Rocco, et al.. (2024). High-risk features associated with recurrence in stage I lung adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 169(2). 436–444.e6. 10 indexed citations

Resio, Benjamin J., Kay See Tan, Joseph Dycoco, et al.. (2024). Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection. The Annals of Thoracic Surgery. 119(2). 308–315. 3 indexed citations

Li, Yan, Marina K. Baine, Francis M. Bodd, et al.. (2023). Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting. Cancer Cytopathology. 131(8). 495–506. 3 indexed citations

Li, Yan, Shaohua Lu, David Restle, et al.. (2023). Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Factors of Poor Prognosis in Patients With Stages II to III Lung Adenocarcinoma. Journal of Thoracic Oncology. 18(5). 608–619. 11 indexed citations

Connolly, James G., Kay See Tan, Brooke Mastrogiacomo, et al.. (2021). Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma. British Journal of Anaesthesia. 127(1). 75–84. 40 indexed citations

10.

Zauderer, Marjorie G., Anne S. Tsao, Tao Dao, et al.. (2017). A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma. Clinical Cancer Research. 23(24). 7483–7489. 46 indexed citations

11.

Takahashi, Yusuke, Takashi Eguchi, Shaohua Lu, et al.. (2017). Preponderance of High-Grade Histologic Subtype in Autologous Metastases in Lung Adenocarcinoma. American Journal of Respiratory and Critical Care Medicine. 197(6). 816–818. 7 indexed citations

12.

Liu, Yuan, Marty W. Mayo, Neel P. Chudgar, et al.. (2016). CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation. Cancer Research. 76(9). 2675–2686. 28 indexed citations

13.

Morello, Aurore, Michel Sadelain, & Prasad S. Adusumilli. (2015). Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors. Cancer Discovery. 6(2). 133–146. 367 indexed citations breakdown →

14.

Kadota, Kyuichi, Jun‐ichi Nitadori, Hideki Ujiie, et al.. (2015). Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma. Journal of Thoracic Oncology. 10(9). 1301–1310. 50 indexed citations

15.

Rizk, Nabil P., Meier Hsu, Manjit S. Bains, et al.. (2014). A Prospective Trial Comparing Pain and Quality of Life Measures After Anatomic Lung Resection Using Thoracoscopy or Thoracotomy. The Annals of Thoracic Surgery. 98(4). 1160–1166. 89 indexed citations

16.

Yeh, Yi‐Chen, Jun‐ichi Nitadori, Kyuichi Kadota, et al.. (2014). Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤3 cm: accuracy and interobserver agreement. Histopathology. 66(7). 922–938. 112 indexed citations

17.

Kachala, Stefan S., Adam J. Bograd, Jonathan Villena‐Vargas, et al.. (2013). Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma. Clinical Cancer Research. 20(4). 1020–1028. 132 indexed citations

18.

Servais, Elliot L., Christos Colovos, Adam J. Bograd, et al.. (2012). Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients. Clinical Cancer Research. 18(9). 2478–2489. 151 indexed citations

19.

Rizk, Nabil P., Elliot L. Servais, Laura H. Tang, et al.. (2012). Tissue and Serum Mesothelin Are Potential Markers of Neoplastic Progression in Barrett's Associated Esophageal Adenocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 21(3). 482–486. 35 indexed citations

20.

Suzuki, Kei, Stefan S. Kachala, Kyuichi Kadota, et al.. (2011). Prognostic Immune Markers in Non–Small Cell Lung Cancer. Clinical Cancer Research. 17(16). 5247–5256. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact